Diseases
Research conducted by a team of scientists at the First Affiliated Hospital of Sun Yat-sen University has shed new light on the relationship between hypothyroidism and coronary heart disease. The study, published in the Journal of the Endocrine Society, utilized Mendelian randomization to examine the causal effect of hypothyroidism on
Diseases
A study published in the journal Cancer has shed light on the impact of measurable residual disease (MRD) dynamics in adults with lysine methyltransferase 2a rearrangement (KMT2Ar) in acute myeloid leukemia (AML) during the peritransplant period. The research, conducted by a team from Peking University People's Hospital, involved
Diseases
Investigators at the University of Washington, in collaboration with the Fred Hutchinson Cancer Center, have conducted a comprehensive study to examine the impact of donor graft cell composition on post-HCT outcomes in acute myeloid leukemia (AML) patients. The research team utilized an electronic database to identify adults with AML who
Diseases
Researchers at Yonsei University College of Medicine in Seoul, South Korea, have published a study on the impact of CD34+ cell dose on outcomes in haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) in acute leukemia. The study, which was conducted between 2010 and 2020, involved 81 patients with acute leukemia
Alzheimer's disease
Ruth Langsford, TV presenter, has been dealing with a challenging few years, including her parents' struggles with Alzheimer's disease. Her mum, Joan, lives in a care home, and Ruth has taken on the role of her main carer. Despite the difficulties, Ruth focuses on caring for her
Diseases
Territory families have significantly reduced healthcare costs, with 8000 young Territorians receiving a free Meningococcal B vaccine since the government expanded the program. The initiative, launched by the CLP government in the beginning of the year, protects kids against a deadly disease. The vaccination program has been expanded to include
Diseases
The development of biosimilars offers a cost-effective solution for treating immune-related diseases, but regulatory inconsistencies across different countries and agencies hinder their adoption. According to researchers at Wake Forest University School of Medicine, the current regulatory framework for biologics and biosimilars is complex and varies across the US, Europe, and
Diseases
The Food and Drug Administration (FDA) has authorized numerous artificial intelligence (AI)- and machine learning-based devices for Alzheimer's disease and related dementias, but the evidence supporting these authorizations is often limited and lacks transparency. A recent study has highlighted the need for more robust and standardized reporting
Diseases
New research published in the journal Proteins: Structure, Function, and Bioinformatics has shed light on the interactions between amyloid-beta peptides and neuronal membranes in the development of Alzheimer's disease. Investigating the role of ganglioside monosialotetrahexosylganglioside (GM1) lipids in the disease process, researchers from the University of Paris discovered
Diseases
Crohn's disease is a chronic inflammatory condition that affects the gastrointestinal tract, causing inflammation and symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. Despite current treatments, there is still a need for effective therapies to manage symptoms and improve quality of life for patients. DelveInsight&
Diseases
Researchers from the University of Cambridge have made a breakthrough in the treatment of Alzheimer's Disease by employing an AI-guided tool to enhance precision in patient stratification. The study, published in Nature Communications, analyzed data from the AMARANTH trial of lanabecestat, a BACE1 inhibitor, and found that the
Diseases
Research conducted at the University of Oxford has shed light on the effectiveness of vasodilatory drugs in treating small vessel disease, a condition affecting blood flow to the brain. The study, led by Karolina Feakins and colleagues, aimed to identify the most sensitive physiological markers of treatment response to sildenafil,
